US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Allogene Therapeutics Inc.

1.23

-0.0400-3.15%

Post-market: 1.230.00000.00%19:56 EDT

Volume:2.56M

Turnover:3.15M

Market Cap:272.91M

PE:-1.11

High:1.27

Open:1.26

Low:1.21

Close:1.27

52wk High:3.78

52wk Low:0.8621

Shares:221.88M

Float Shares:164.98M

Volume Ratio:0.64

T/O Rate:1.55%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.1091

EPS(LYR):-1.3222

ROE:-55.12%

ROA:-26.98%

PB:0.79

PE(LYR):-0.93

Loading ...

Overview Company News Filings

Allogene Therapeutics Faces Potential Risk as Cellectis Hit with Patent Infringement Lawsuit Over TALEN Gene-Editing Technology

J.P. Morgan Sticks to Its Sell Rating for Allogene Therapeutics (ALLO)

U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity

Allogene Therapeutics Inc : JP Morgan Cuts to Underweight From Neutral

THOMSON REUTERS

Allogene Therapeutics Initiates Pivotal Phase 2 ALPHA3 Trial for Cema-Cel in Large B-Cell Lymphoma

Allogene Therapeutics Reports Quarterly Financial Results; Key Milestones Achieved in Clinical Trials

BRIEF-Allogene Therapeutics Q2 EPS USD -0.23

Allogene Therapeutics Q2 Net Income USD -50.943 Million

THOMSON REUTERS

Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC

Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update

THOMSON REUTERS

JPMorgan Downgrades Allogene Therapeutics to Neutral From Overweight

MT Newswires Live

U.S. RESEARCH ROUNDUP-Carvana, Federated Hermes, Ralph Lauren

Allogene Therapeutics Inc : JP Morgan Cuts to Neutral From Overweight

THOMSON REUTERS

Allogene Therapeutics Inc expected to post a loss of 27 cents a share - Earnings Preview

BRIEF-Allogene Therapeutics Selects Standard FC Regimen For Alpha3 Study - SEC Filing

Allogene Therapeutics Inc: None of Co's Trials Open to Enrollment or Pipeline Programs Include Allo-647

THOMSON REUTERS

Allogene Therapeutics Inc - Fc Plus Allo-647 Arm Closed Due to Adverse Event - SEC Filing

THOMSON REUTERS

Allogene Therapeutics: Will Advance Next-Generation Allocar T Product Candidates Using Proprietary Dagger Platform Technology

THOMSON REUTERS

Allogene Therapeutics Announces Launch of ALPHA3 Study Using Standard Fludarabine and Cyclophosphamide for Large B-Cell Lymphoma

Allogene Therapeutics Inc. Conducted Annual Stockholders Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALLO/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALLO","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALLO\",,,,,undefined,":{"symbol":"ALLO","market":"US","secType":"STK","nameCN":"Allogene Therapeutics Inc.","latestPrice":1.23,"timestamp":1760731200000,"preClose":1.27,"halted":0,"volume":2556266,"hourTrading":{"tag":"盘后","latestPrice":1.23,"preClose":1.23,"latestTime":"19:56 EDT","volume":7958,"amount":9801.61,"timestamp":1760745378520},"delay":0,"floatShares":164975822,"shares":221881029,"eps":-1.109119,"marketStatus":"Market Closed","change":-0.04,"latestTime":"10-17 16:00:00 EDT","open":1.255,"high":1.27,"low":1.21,"amount":3149502.7406456,"amplitude":0.047244,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.109119,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1760947200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1539230400000,"exchange":"NASDAQ","adjPreClose":1.27,"preHourTrading":{"tag":"盘前","latestPrice":1.2501,"preClose":1.27,"latestTime":"09:23 EDT","volume":7668,"amount":9670.6086192,"timestamp":1760707397719},"postHourTrading":{"tag":"盘后","latestPrice":1.23,"preClose":1.23,"latestTime":"19:56 EDT","volume":7958,"amount":9801.61,"timestamp":1760745378520},"volumeRatio":0.6371921991573295,"impliedVol":2.1921,"impliedVolPercentile":0.836},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALLO\",,,,,undefined,":{"symbol":"ALLO","floatShares":164975822,"roa":"-26.98%","roe":"-55.12%","lyrEps":-1.32225,"volumeRatio":0.6371921991573295,"shares":221881029,"dividePrice":0,"high":1.27,"amplitude":0.047244,"preClose":1.27,"low":1.21,"week52Low":0.8621,"pbRate":"0.79","week52High":3.78,"institutionHeld":0,"latestPrice":1.23,"eps":-1.109119,"divideRate":0,"volume":2556266,"delay":0,"ttmEps":-1.109119,"open":1.255,"prevYearClose":2.13,"prevWeekClose":1.23,"prevMonthClose":1.24,"prevQuarterClose":1.24,"fiveDayClose":1.23,"twentyDayClose":1.16,"sixtyDayClose":1.51},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALLO\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-08-13","symbol":"ALLO","fiscalQuarterEnding":"2025/06","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.23},{"market":"US","date":"2025-05-13","symbol":"ALLO","fiscalQuarterEnding":"2025/03","expectedEps":-0.28,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747108800000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2025-03-13","symbol":"ALLO","fiscalQuarterEnding":"2024/12","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741838400000,"reportTimeType":"post","actualEps":-0.28},{"market":"US","date":"2024-11-07","symbol":"ALLO","fiscalQuarterEnding":"2024/09","expectedEps":-0.34,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730955600000,"reportTimeType":"post","actualEps":-0.27},{"market":"US","date":"2024-08-07","symbol":"ALLO","fiscalQuarterEnding":"2024/06","expectedEps":-0.35,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-0.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALLO\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALLO\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3571,"buy":0.4286,"hold":0.1429,"sell":0.0714,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4286,"analysts":14,"updateTime":1760241600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALLO\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALLO","date":"2025-10-17","current":-1.108988,"percent":0.91193,"low":-22.277423,"twenty":-11.068438,"median":-2.503782,"eighty":-1.51608,"high":-0.825952,"avg":-5.861168,"sd":6.021946,"marketCap":281788906},"quantilePoints":[{"date":"2020-10-23","current":-22.252902,"twenty":-30.499998,"median":-21.914568,"eighty":-15.494275,"marketCap":5056282103},{"date":"2020-10-30","current":-20.793896,"twenty":-30.117541,"median":-21.899539,"eighty":-15.519547,"marketCap":4724768290},{"date":"2020-11-06","current":-16.069607,"twenty":-29.763062,"median":-21.864819,"eighty":-15.5887,"marketCap":3899788225},{"date":"2020-11-13","current":-18.537852,"twenty":-29.652871,"median":-21.833475,"eighty":-15.667503,"marketCap":4498784474},{"date":"2020-11-20","current":-18.052296,"twenty":-29.579943,"median":-21.805392,"eighty":-15.676049,"marketCap":4380949146},{"date":"2020-11-27","current":-18.219928,"twenty":-29.522101,"median":-21.773611,"eighty":-15.706189,"marketCap":4421630391},{"date":"2020-12-04","current":-19.451161,"twenty":-29.361862,"median":-21.722315,"eighty":-15.79419,"marketCap":4720427114},{"date":"2020-12-11","current":-15.84995,"twenty":-29.3261,"median":-21.682404,"eighty":-15.838198,"marketCap":3846481767},{"date":"2020-12-18","current":-15.688098,"twenty":-29.203647,"median":-21.66746,"eighty":-15.734976,"marketCap":3807203325},{"date":"2020-12-24","current":-15.797926,"twenty":-29.199397,"median":-21.632371,"eighty":-15.783758,"marketCap":3833856554},{"date":"2020-12-31","current":-14.589816,"twenty":-29.129678,"median":-21.578578,"eighty":-15.683214,"marketCap":3540671036},{"date":"2021-01-08","current":-16.11007,"twenty":-29.094985,"median":-21.512647,"eighty":-15.665105,"marketCap":3909607836},{"date":"2021-01-15","current":-18.722826,"twenty":-29.085837,"median":-21.484956,"eighty":-15.668424,"marketCap":4543674123},{"date":"2021-01-22","current":-17.780615,"twenty":-29.081387,"median":-21.441682,"eighty":-15.679632,"marketCap":4315017475},{"date":"2021-01-29","current":-20.058106,"twenty":-29.079226,"median":-21.417075,"eighty":-15.687578,"marketCap":4867721274},{"date":"2021-02-05","current":-20.358689,"twenty":-29.059413,"median":-21.366276,"eighty":-15.695035,"marketCap":4940666953},{"date":"2021-02-12","current":-20.075448,"twenty":-28.895623,"median":-21.330672,"eighty":-15.713532,"marketCap":4871929678},{"date":"2021-02-19","current":-20.069667,"twenty":-28.779198,"median":-21.3211,"eighty":-15.747172,"marketCap":4870526877},{"date":"2021-02-26","current":-19.510296,"twenty":-28.705134,"median":-21.268993,"eighty":-15.789425,"marketCap":4881885762},{"date":"2021-03-05","current":-19.111209,"twenty":-28.62932,"median":-21.180345,"eighty":-15.813122,"marketCap":4782025812},{"date":"2021-03-12","current":-21.629392,"twenty":-28.549665,"median":-21.223136,"eighty":-15.840479,"marketCap":5412128036},{"date":"2021-03-19","current":-20.803113,"twenty":-28.424864,"median":-21.180345,"eighty":-15.848374,"marketCap":5205375744},{"date":"2021-03-26","current":-18.987548,"twenty":-28.40809,"median":-21.126559,"eighty":-15.84995,"marketCap":4751083292},{"date":"2021-04-01","current":-19.633957,"twenty":-28.393688,"median":-21.081445,"eighty":-15.853418,"marketCap":4912828282},{"date":"2021-04-09","current":-18.447938,"twenty":-28.354062,"median":-21.006281,"eighty":-15.878853,"marketCap":4616061386},{"date":"2021-04-16","current":-18.273688,"twenty":-28.264241,"median":-20.976017,"eighty":-15.933588,"marketCap":4572460563},{"date":"2021-04-23","current":-19.462576,"twenty":-28.191593,"median":-20.927873,"eighty":-15.982492,"marketCap":4869945125},{"date":"2021-04-30","current":-17.483522,"twenty":-28.153287,"median":-20.900528,"eighty":-16.044634,"marketCap":4374744429},{"date":"2021-05-07","current":-18.574304,"twenty":-28.140827,"median":-20.824306,"eighty":-16.056451,"marketCap":4248983398},{"date":"2021-05-14","current":-17.015102,"twenty":-28.110712,"median":-20.785365,"eighty":-16.066082,"marketCap":3892306577},{"date":"2021-05-21","current":-16.09938,"twenty":-28.045215,"median":-20.757114,"eighty":-16.075562,"marketCap":3682829714},{"date":"2021-05-28","current":-15.901386,"twenty":-27.798929,"median":-20.702003,"eighty":-15.982492,"marketCap":3637537419},{"date":"2021-06-04","current":-14.731984,"twenty":-27.771552,"median":-20.677935,"eighty":-15.867292,"marketCap":3370029804},{"date":"2021-06-11","current":-16.148878,"twenty":-27.752287,"median":-20.584126,"eighty":-15.84995,"marketCap":3694152788},{"date":"2021-06-18","current":-15.146534,"twenty":-27.745135,"median":-20.567167,"eighty":-15.783758,"marketCap":3464860546},{"date":"2021-06-25","current":-14.960915,"twenty":-27.705487,"median":-20.54455,"eighty":-15.697205,"marketCap":3422399019},{"date":"2021-07-02","current":-16.26025,"twenty":-27.672486,"median":-20.524004,"eighty":-15.697205,"marketCap":3719629703},{"date":"2021-07-09","current":-14.911416,"twenty":-27.651352,"median":-20.43363,"eighty":-15.668424,"marketCap":3411075946},{"date":"2021-07-16","current":-14.001882,"twenty":-27.614367,"median":-20.349588,"eighty":-15.61339,"marketCap":3203014467},{"date":"2021-07-23","current":-13.643018,"twenty":-27.477084,"median":-20.242529,"eighty":-15.573595,"marketCap":3120922183},{"date":"2021-07-30","current":-13.581145,"twenty":-27.372009,"median":-20.19926,"eighty":-15.486486,"marketCap":3106768340},{"date":"2021-08-06","current":-13.937332,"twenty":-27.187994,"median":-20.183031,"eighty":-15.440342,"marketCap":3327091981},{"date":"2021-08-13","current":-12.769931,"twenty":-27.13327,"median":-20.135965,"eighty":-15.396829,"marketCap":3048412481},{"date":"2021-08-20","current":-13.967112,"twenty":-27.128016,"median":-20.084647,"eighty":-15.357651,"marketCap":3334201152},{"date":"2021-08-27","current":-14.532944,"twenty":-27.087978,"median":-20.058106,"eighty":-15.319398,"marketCap":3469275399},{"date":"2021-09-03","current":-15.17025,"twenty":-27.066547,"median":-19.991439,"eighty":-15.277942,"marketCap":3621411656},{"date":"2021-09-10","current":-14.735453,"twenty":-26.951342,"median":-19.940072,"eighty":-15.211389,"marketCap":3517617761},{"date":"2021-09-17","current":-15.116645,"twenty":-26.795343,"median":-19.884693,"eighty":-15.124129,"marketCap":3608615148},{"date":"2021-09-24","current":-15.283416,"twenty":-26.678135,"median":-19.849922,"eighty":-15.11715,"marketCap":3648426505},{"date":"2021-10-01","current":-14.604418,"twenty":-26.569222,"median":-19.821108,"eighty":-15.112387,"marketCap":3486337409},{"date":"2021-10-08","current":-7.820392,"twenty":-26.52467,"median":-19.746249,"eighty":-15.06736,"marketCap":1866868278},{"date":"2021-10-15","current":-9.815694,"twenty":-26.488509,"median":-19.739643,"eighty":-15.039637,"marketCap":2343182728},{"date":"2021-10-22","current":-9.422589,"twenty":-26.410782,"median":-19.66854,"eighty":-14.968339,"marketCap":2249341672},{"date":"2021-10-29","current":-10.268359,"twenty":-26.360977,"median":-19.633957,"eighty":-14.938394,"marketCap":2451242126},{"date":"2021-11-05","current":-11.448707,"twenty":-26.35097,"median":-19.577031,"eighty":-14.909523,"marketCap":2870270991},{"date":"2021-11-12","current":-10.948466,"twenty":-26.268966,"median":-19.520526,"eighty":-14.896677,"marketCap":2744856965},{"date":"2021-11-19","current":-10.69266,"twenty":-25.997664,"median":-19.458331,"eighty":-14.830197,"marketCap":2680724793},{"date":"2021-11-26","current":-10.220842,"twenty":-25.82651,"median":-19.416087,"eighty":-14.809383,"marketCap":2562436565},{"date":"2021-12-03","current":-10.016198,"twenty":-25.773439,"median":-19.283528,"eighty":-14.742014,"marketCap":2511130827},{"date":"2021-12-10","current":-10.249265,"twenty":-25.711764,"median":-19.163016,"eighty":-14.695169,"marketCap":2569562362},{"date":"2021-12-17","current":-8.987292,"twenty":-25.583781,"median":-19.115579,"eighty":-14.620796,"marketCap":2253176979},{"date":"2021-12-23","current":-8.902023,"twenty":-25.481704,"median":-19.099967,"eighty":-14.591026,"marketCap":2231799589},{"date":"2021-12-31","current":-8.481366,"twenty":-25.460584,"median":-19.052311,"eighty":-14.49675,"marketCap":2126337794},{"date":"2022-01-07","current":-7.65142,"twenty":-25.434926,"median":-18.972964,"eighty":-14.45075,"marketCap":1918264525},{"date":"2022-01-14","current":-7.549098,"twenty":-25.370845,"median":-18.912042,"eighty":-14.374511,"marketCap":1892611656},{"date":"2022-01-21","current":-6.457662,"twenty":-25.231783,"median":-18.839368,"eighty":-14.322288,"marketCap":1618981055},{"date":"2022-01-28","current":-6.037004,"twenty":-25.124812,"median":-18.790783,"eighty":-14.276831,"marketCap":1513519261},{"date":"2022-02-04","current":-6.264387,"twenty":-25.073649,"median":-18.741054,"eighty":-14.246482,"marketCap":1570525636},{"date":"2022-02-11","current":-5.76983,"twenty":-24.932692,"median":-18.689285,"eighty":-14.211106,"marketCap":1446536770},{"date":"2022-02-18","current":-5.286642,"twenty":-24.919572,"median":-18.675482,"eighty":-14.155515,"marketCap":1325398223},{"date":"2022-02-25","current":-5.237841,"twenty":-24.910169,"median":-18.641491,"eighty":-14.089501,"marketCap":1346151378},{"date":"2022-03-04","current":-4.465773,"twenty":-24.856433,"median":-18.614852,"eighty":-13.975129,"marketCap":1147726096},{"date":"2022-03-11","current":-4.537981,"twenty":-24.80629,"median":-18.575761,"eighty":-13.919313,"marketCap":1166283856},{"date":"2022-03-18","current":-5.421138,"twenty":-24.791816,"median":-18.537852,"eighty":-13.824271,"marketCap":1393259539},{"date":"2022-03-25","current":-5.360039,"twenty":-24.745062,"median":-18.517177,"eighty":-13.759752,"marketCap":1377556819},{"date":"2022-04-01","current":-5.24895,"twenty":-24.663369,"median":-18.481663,"eighty":-13.698958,"marketCap":1349006418},{"date":"2022-04-08","current":-4.910129,"twenty":-24.556916,"median":-18.469454,"eighty":-13.641781,"marketCap":1261927697},{"date":"2022-04-14","current":-4.608672,"twenty":-24.523728,"median":-18.439507,"eighty":-13.603773,"marketCap":1184451691},{"date":"2022-04-22","current":-4.35729,"twenty":-24.477635,"median":-18.313035,"eighty":-13.564932,"marketCap":1119845235},{"date":"2022-04-29","current":-4.665479,"twenty":-24.441832,"median":-18.271722,"eighty":-13.51369,"marketCap":1199051399},{"date":"2022-05-06","current":-4.338635,"twenty":-24.350625,"median":-18.24883,"eighty":-13.47653,"marketCap":1318250882},{"date":"2022-05-13","current":-3.41703,"twenty":-24.272198,"median":-18.214147,"eighty":-13.43938,"marketCap":1038230270},{"date":"2022-05-20","current":-3.535184,"twenty":-24.194972,"median":-18.163547,"eighty":-13.367297,"marketCap":1074130348},{"date":"2022-05-27","current":-3.780946,"twenty":-24.101793,"median":-18.077113,"eighty":-13.243821,"marketCap":1148802512},{"date":"2022-06-03","current":-3.932183,"twenty":-24.060108,"median":-18.06159,"eighty":-13.190251,"marketCap":1194754612},{"date":"2022-06-10","current":-4.603301,"twenty":-24.027743,"median":-17.98293,"eighty":-13.117204,"marketCap":1398667058},{"date":"2022-06-17","current":-5.179895,"twenty":-23.989114,"median":-17.951138,"eighty":-12.938707,"marketCap":1573859441},{"date":"2022-06-24","current":-5.803751,"twenty":-23.979164,"median":-17.921762,"eighty":-12.772357,"marketCap":1763411855},{"date":"2022-07-01","current":-5.439835,"twenty":-23.96372,"median":-17.857317,"eighty":-12.530495,"marketCap":1652839614},{"date":"2022-07-08","current":-5.685597,"twenty":-23.901946,"median":-17.780615,"eighty":-12.328703,"marketCap":1727511777},{"date":"2022-07-15","current":-6.054239,"twenty":-23.879665,"median":-17.691917,"eighty":-11.170164,"marketCap":1839520022},{"date":"2022-07-22","current":-6.314179,"twenty":-23.828383,"median":-17.626932,"eighty":-10.948466,"marketCap":1918500195},{"date":"2022-07-29","current":-6.134584,"twenty":-23.705543,"median":-17.59185,"eighty":-10.800667,"marketCap":1863932075},{"date":"2022-08-05","current":-7.306677,"twenty":-23.697251,"median":-17.538967,"eighty":-10.69266,"marketCap":2220060854},{"date":"2022-08-12","current":-8.062204,"twenty":-23.570911,"median":-17.452841,"eighty":-10.510754,"marketCap":2480667731},{"date":"2022-08-19","current":-6.921811,"twenty":-23.514837,"median":-17.370093,"eighty":-10.266318,"marketCap":2129779078},{"date":"2022-08-26","current":-6.59465,"twenty":-23.443168,"median":-17.343792,"eighty":-10.220842,"marketCap":2029114300},{"date":"2022-09-02","current":-6.636713,"twenty":-23.37196,"median":-17.295567,"eighty":-9.815694,"marketCap":2042056915},{"date":"2022-09-09","current":-7.043329,"twenty":-23.333983,"median":-17.225694,"eighty":-9.494063,"marketCap":2167168852},{"date":"2022-09-16","current":-6.389005,"twenty":-23.304303,"median":-17.168273,"eighty":-9.413059,"marketCap":1965839297},{"date":"2022-09-23","current":-4.963514,"twenty":-23.295891,"median":-17.123016,"eighty":-8.970238,"marketCap":1527228481},{"date":"2022-09-30","current":-5.047641,"twenty":-23.22545,"median":-17.01924,"eighty":-8.791743,"marketCap":1553113710},{"date":"2022-10-07","current":-4.841996,"twenty":-23.18815,"median":-16.933399,"eighty":-8.734897,"marketCap":1489838707},{"date":"2022-10-14","current":-4.757869,"twenty":-23.163275,"median":-16.832624,"eighty":-8.377907,"marketCap":1463953478},{"date":"2022-10-21","current":-4.701784,"twenty":-23.131767,"median":-16.626752,"eighty":-8.053946,"marketCap":1446696659},{"date":"2022-10-28","current":-5.03362,"twenty":-23.123748,"median":-16.609019,"eighty":-7.819568,"marketCap":1548799505},{"date":"2022-11-04","current":-4.308044,"twenty":-23.118497,"median":-16.462729,"eighty":-7.719634,"marketCap":1346922838},{"date":"2022-11-11","current":-4.621692,"twenty":-23.078037,"median":-16.372736,"eighty":-7.512226,"marketCap":1444985743},{"date":"2022-11-18","current":-4.723166,"twenty":-23.040787,"median":-16.295044,"eighty":-7.268603,"marketCap":1476711976},{"date":"2022-11-25","current":-4.967627,"twenty":-23.028761,"median":-16.231769,"eighty":-7.107827,"marketCap":1553143358},{"date":"2022-12-02","current":-4.363393,"twenty":-22.975759,"median":-16.162506,"eighty":-6.958297,"marketCap":1364228056},{"date":"2022-12-09","current":-4.040521,"twenty":-22.92282,"median":-16.136504,"eighty":-6.795851,"marketCap":1263280949},{"date":"2022-12-16","current":-3.187214,"twenty":-22.884679,"median":-16.118741,"eighty":-6.737666,"marketCap":996492164},{"date":"2022-12-23","current":-2.74903,"twenty":-22.855762,"median":-16.09938,"eighty":-6.648267,"marketCap":859492517},{"date":"2022-12-30","current":-2.901242,"twenty":-22.845812,"median":-16.065201,"eighty":-6.624678,"marketCap":907081868},{"date":"2023-01-06","current":-2.808992,"twenty":-22.842858,"median":-16.042226,"eighty":-6.551135,"marketCap":878239837},{"date":"2023-01-13","current":-3.256401,"twenty":-22.839916,"median":-15.931803,"eighty":-6.459821,"marketCap":1018123687},{"date":"2023-01-20","current":-3.021166,"twenty":-22.833946,"median":-15.884339,"eighty":-6.44509,"marketCap":944576508},{"date":"2023-01-27","current":-3.653074,"twenty":-22.804627,"median":-15.84995,"eighty":-6.403977,"marketCap":1142144419},{"date":"2023-02-03","current":-3.588499,"twenty":-22.792366,"median":-15.822247,"eighty":-6.365636,"marketCap":1121954998},{"date":"2023-02-10","current":-3.168765,"twenty":-22.752014,"median":-15.783758,"eighty":-6.281441,"marketCap":990723757},{"date":"2023-02-17","current":-3.320976,"twenty":-22.724933,"median":-15.698432,"eighty":-6.150644,"marketCap":1038313108},{"date":"2023-02-24","current":-2.855117,"twenty":-22.720065,"median":-15.692652,"eighty":-6.050792,"marketCap":892660853},{"date":"2023-03-03","current":-2.602093,"twenty":-22.718848,"median":-15.668884,"eighty":-5.957523,"marketCap":865539324},{"date":"2023-03-10","current":-2.476115,"twenty":-22.699195,"median":-15.650358,"eighty":-5.791024,"marketCap":823635083},{"date":"2023-03-17","current":-2.38489,"twenty":-22.694036,"median":-15.59202,"eighty":-5.754599,"marketCap":793290632},{"date":"2023-03-24","current":-2.180719,"twenty":-22.650082,"median":-15.578958,"eighty":-5.643062,"marketCap":725376862},{"date":"2023-03-31","current":-2.145966,"twenty":-22.606719,"median":-15.536778,"eighty":-5.533933,"marketCap":713817072},{"date":"2023-04-06","current":-2.145966,"twenty":-22.596133,"median":-15.486836,"eighty":-5.526161,"marketCap":713817072},{"date":"2023-04-14","current":-2.193751,"twenty":-22.59183,"median":-15.476469,"eighty":-5.47859,"marketCap":729711784},{"date":"2023-04-21","current":-2.167687,"twenty":-22.582762,"median":-15.444878,"eighty":-5.423849,"marketCap":721041941},{"date":"2023-04-28","current":-2.331585,"twenty":-22.567942,"median":-15.411502,"eighty":-5.378822,"marketCap":775559814},{"date":"2023-05-05","current":-2.67629,"twenty":-22.556495,"median":-15.387839,"eighty":-5.296718,"marketCap":940678449},{"date":"2023-05-12","current":-2.564259,"twenty":-22.5382,"median":-15.360906,"eighty":-5.264421,"marketCap":901301211},{"date":"2023-05-19","current":-2.522766,"twenty":-22.523168,"median":-15.347235,"eighty":-5.220067,"marketCap":886717049},{"date":"2023-05-26","current":-2.26966,"twenty":-22.494685,"median":-15.329523,"eighty":-5.146724,"marketCap":797753661},{"date":"2023-06-02","current":-2.207421,"twenty":-22.461519,"median":-15.318827,"eighty":-5.12616,"marketCap":775877418},{"date":"2023-06-09","current":-2.406586,"twenty":-22.436936,"median":-15.307241,"eighty":-5.087067,"marketCap":845881396},{"date":"2023-06-16","current":-2.062196,"twenty":-22.431982,"median":-15.280863,"eighty":-5.062594,"marketCap":724832851},{"date":"2023-06-23","current":-1.950165,"twenty":-22.42371,"median":-15.264093,"eighty":-5.040163,"marketCap":685455614},{"date":"2023-06-30","current":-1.900373,"twenty":-22.420352,"median":-15.20471,"eighty":-4.999,"marketCap":667954619},{"date":"2023-07-07","current":-2.082942,"twenty":-22.399189,"median":-15.158392,"eighty":-4.959528,"marketCap":732124932},{"date":"2023-07-14","current":-2.163853,"twenty":-22.385151,"median":-15.117486,"eighty":-4.907907,"marketCap":760564048},{"date":"2023-07-21","current":-2.190823,"twenty":-22.379709,"median":-15.097383,"eighty":-4.870137,"marketCap":770043753},{"date":"2023-07-28","current":-1.962613,"twenty":-22.365629,"median":-15.070241,"eighty":-4.834519,"marketCap":689830862},{"date":"2023-08-04","current":-2.429176,"twenty":-22.333634,"median":-15.048949,"eighty":-4.780355,"marketCap":861599516},{"date":"2023-08-11","current":-1.989656,"twenty":-22.302039,"median":-15.039215,"eighty":-4.750531,"marketCap":705706996},{"date":"2023-08-18","current":-1.890409,"twenty":-22.281125,"median":-14.976471,"eighty":-4.726099,"marketCap":670505460},{"date":"2023-08-25","current":-1.800615,"twenty":-22.26271,"median":-14.959059,"eighty":-4.690269,"marketCap":638656450},{"date":"2023-09-01","current":-1.838423,"twenty":-22.254128,"median":-14.935942,"eighty":-4.655464,"marketCap":652066559},{"date":"2023-09-08","current":-1.890409,"twenty":-22.226501,"median":-14.915859,"eighty":-4.613716,"marketCap":670505460},{"date":"2023-09-15","current":-1.866779,"twenty":-22.199407,"median":-14.907739,"eighty":-4.562564,"marketCap":662124141},{"date":"2023-09-22","current":-1.758081,"twenty":-22.155099,"median":-14.902096,"eighty":-4.535759,"marketCap":623570077},{"date":"2023-09-29","current":-1.611574,"twenty":-22.125027,"median":-14.890312,"eighty":-4.47888,"marketCap":571605904},{"date":"2023-10-06","current":-1.488697,"twenty":-22.083887,"median":-14.828304,"eighty":-4.453624,"marketCap":528023049},{"date":"2023-10-13","current":-1.398903,"twenty":-22.021504,"median":-14.806926,"eighty":-4.392913,"marketCap":496174040},{"date":"2023-10-20","current":-1.408355,"twenty":-21.920407,"median":-14.732656,"eighty":-4.341249,"marketCap":499526567},{"date":"2023-10-27","current":-1.24767,"twenty":-21.858588,"median":-14.678091,"eighty":-4.324649,"marketCap":442533603},{"date":"2023-11-03","current":-1.500595,"twenty":-21.791299,"median":-14.597163,"eighty":-4.250351,"marketCap":499480406},{"date":"2023-11-10","current":-1.271472,"twenty":-21.701761,"median":-14.505855,"eighty":-4.13646,"marketCap":423215804},{"date":"2023-11-17","current":-1.420611,"twenty":-21.666847,"median":-14.444042,"eighty":-3.884921,"marketCap":472857420},{"date":"2023-11-24","current":-1.435778,"twenty":-21.606973,"median":-14.367423,"eighty":-3.736519,"marketCap":477905720},{"date":"2023-12-01","current":-1.188055,"twenty":-21.531996,"median":-14.285577,"eighty":-3.670601,"marketCap":395450155},{"date":"2023-12-08","current":-1.274,"twenty":-21.460314,"median":-14.255927,"eighty":-3.607628,"marketCap":424057188},{"date":"2023-12-15","current":-1.370055,"twenty":-21.374979,"median":-14.211106,"eighty":-3.560824,"marketCap":456029754},{"date":"2023-12-22","current":-1.395333,"twenty":-21.322326,"median":-14.13984,"eighty":-3.533294,"marketCap":464443587},{"date":"2023-12-29","current":-1.653166,"twenty":-21.268379,"median":-14.008069,"eighty":-3.467127,"marketCap":550264684},{"date":"2024-01-05","current":-1.713833,"twenty":-21.128686,"median":-13.967112,"eighty":-3.374494,"marketCap":570457884},{"date":"2024-01-12","current":-1.622833,"twenty":-20.999951,"median":-13.847237,"eighty":-3.288105,"marketCap":540168085},{"date":"2024-01-19","current":-1.617777,"twenty":-20.926148,"median":-13.775851,"eighty":-3.237951,"marketCap":538485318},{"date":"2024-01-26","current":-1.617777,"twenty":-20.843295,"median":-13.725947,"eighty":-3.189059,"marketCap":538485318},{"date":"2024-02-02","current":-1.875611,"twenty":-20.757114,"median":-13.643018,"eighty":-3.045151,"marketCap":624306416},{"date":"2024-02-09","current":-2.209277,"twenty":-20.678726,"median":-13.581145,"eighty":-2.954746,"marketCap":735369012},{"date":"2024-02-16","current":-2.507555,"twenty":-20.569541,"median":-13.523798,"eighty":-2.866187,"marketCap":834652243},{"date":"2024-02-23","current":-2.204222,"twenty":-20.53631,"median":-13.479021,"eighty":-2.792973,"marketCap":733686246},{"date":"2024-03-01","current":-2.482277,"twenty":-20.368481,"median":-13.450518,"eighty":-2.74483,"marketCap":826238410},{"date":"2024-03-08","current":-2.815944,"twenty":-20.232312,"median":-13.366427,"eighty":-2.733115,"marketCap":937301007},{"date":"2024-03-15","current":-2.316309,"twenty":-20.232312,"median":-13.215177,"eighty":-2.663292,"marketCap":758046859},{"date":"2024-03-22","current":-2.263068,"twenty":-20.232312,"median":-13.137784,"eighty":-2.619459,"marketCap":740622924},{"date":"2024-03-28","current":-2.304402,"twenty":-20.232312,"median":-12.979561,"eighty":-2.590948,"marketCap":754150284},{"date":"2024-04-05","current":-2.092563,"twenty":-20.235598,"median":-12.656765,"eighty":-2.565844,"marketCap":684822567},{"date":"2024-04-12","current":-2.061562,"twenty":-20.235598,"median":-12.436968,"eighty":-2.524426,"marketCap":674677048},{"date":"2024-04-19","current":-1.78772,"twenty":-20.235598,"median":-11.170164,"eighty":-2.507555,"marketCap":585058292},{"date":"2024-04-26","current":-1.489357,"twenty":-20.232312,"median":-10.939939,"eighty":-2.476779,"marketCap":487414450},{"date":"2024-05-03","current":-1.549349,"twenty":-20.232312,"median":-10.763718,"eighty":-2.449125,"marketCap":507047607},{"date":"2024-05-10","current":-1.491965,"twenty":-20.232312,"median":-10.570442,"eighty":-2.423446,"marketCap":488268066},{"date":"2024-05-17","current":-2.150009,"twenty":-20.232312,"median":-10.267339,"eighty":-2.404926,"marketCap":628441086},{"date":"2024-05-24","current":-1.814293,"twenty":-20.232312,"median":-10.217798,"eighty":-2.379795,"marketCap":530312411},{"date":"2024-05-31","current":-1.785721,"twenty":-20.232312,"median":-9.802255,"eighty":-2.357966,"marketCap":521961035},{"date":"2024-06-07","current":-1.65715,"twenty":-20.232312,"median":-9.458326,"eighty":-2.340512,"marketCap":484379840},{"date":"2024-06-14","current":-1.678578,"twenty":-20.232312,"median":-9.154314,"eighty":-2.32815,"marketCap":490643372},{"date":"2024-06-21","current":-1.821436,"twenty":-20.235598,"median":-8.799701,"eighty":-2.306469,"marketCap":532400255},{"date":"2024-06-28","current":-1.664292,"twenty":-20.235598,"median":-8.725802,"eighty":-2.268805,"marketCap":486467684},{"date":"2024-07-05","current":-1.514292,"twenty":-20.235598,"median":-8.23693,"eighty":-2.246424,"marketCap":442622957},{"date":"2024-07-12","current":-1.971437,"twenty":-20.235598,"median":-8.016944,"eighty":-2.21653,"marketCap":576244982},{"date":"2024-07-19","current":-2.021437,"twenty":-20.235598,"median":-7.74439,"eighty":-2.210017,"marketCap":590859891},{"date":"2024-07-26","current":-2.142866,"twenty":-20.235598,"median":-7.542986,"eighty":-2.200432,"marketCap":626353242},{"date":"2024-08-02","current":-1.835722,"twenty":-20.235598,"median":-7.197562,"eighty":-2.189973,"marketCap":536575943},{"date":"2024-08-09","current":-1.736216,"twenty":-20.196095,"median":-7.009064,"eighty":-2.17649,"marketCap":485138717},{"date":"2024-08-16","current":-1.713765,"twenty":-20.124888,"median":-6.798736,"eighty":-2.165305,"marketCap":478865371},{"date":"2024-08-23","current":-1.953243,"twenty":-20.048107,"median":-6.720841,"eighty":-2.145966,"marketCap":545781056},{"date":"2024-08-30","current":-1.968211,"twenty":-19.922246,"median":-6.639568,"eighty":-2.132059,"marketCap":549963287},{"date":"2024-09-06","current":-1.803569,"twenty":-19.84994,"median":-6.582722,"eighty":-2.123837,"marketCap":503958753},{"date":"2024-09-13","current":-2.215172,"twenty":-19.747348,"median":-6.457662,"eighty":-2.11573,"marketCap":618970087},{"date":"2024-09-20","current":-2.095433,"twenty":-19.670151,"median":-6.43706,"eighty":-2.11202,"marketCap":585512244},{"date":"2024-09-27","current":-2.177754,"twenty":-19.580759,"median":-6.378078,"eighty":-2.102674,"marketCap":608514511},{"date":"2024-10-04","current":-2.020596,"twenty":-19.45918,"median":-6.281441,"eighty":-2.095433,"marketCap":564601093},{"date":"2024-10-11","current":-1.983178,"twenty":-19.283528,"median":-6.139327,"eighty":-2.083825,"marketCap":554145517},{"date":"2024-10-18","current":-2.125368,"twenty":-19.113831,"median":-6.025635,"eighty":-2.07858,"marketCap":593876705},{"date":"2024-10-25","current":-1.82602,"twenty":-19.019469,"median":-5.792568,"eighty":-2.070244,"marketCap":510232099},{"date":"2024-11-01","current":-2.035564,"twenty":-18.894558,"median":-5.728133,"eighty":-2.063035,"marketCap":568783323},{"date":"2024-11-08","current":-2.27849,"twenty":-18.761339,"median":-5.576662,"eighty":-2.063035,"marketCap":645790040},{"date":"2024-11-15","current":-1.679276,"twenty":-18.685636,"median":-5.526672,"eighty":-2.058046,"marketCap":475955646},{"date":"2024-11-22","current":-1.63489,"twenty":-18.622972,"median":-5.472919,"eighty":-2.050756,"marketCap":463375321},{"date":"2024-11-29","current":-1.834628,"twenty":-18.573596,"median":-5.421138,"eighty":-2.046637,"marketCap":519986785},{"date":"2024-12-06","current":-1.620095,"twenty":-18.506733,"median":-5.360039,"eighty":-2.024094,"marketCap":459181879},{"date":"2024-12-13","current":-1.398164,"twenty":-18.460267,"median":-5.271168,"eighty":-2.012265,"marketCap":396280251},{"date":"2024-12-20","current":-1.383369,"twenty":-18.27539,"median":-5.237841,"eighty":-1.998145,"marketCap":392086810},{"date":"2024-12-27","current":-1.620095,"twenty":-18.240786,"median":-5.150463,"eighty":-1.991967,"marketCap":459181879},{"date":"2025-01-03","current":-1.597902,"twenty":-18.172298,"median":-5.122421,"eighty":-1.985961,"marketCap":452891716},{"date":"2025-01-10","current":-1.520226,"twenty":-18.067166,"median":-5.083674,"eighty":-1.978904,"marketCap":430876147},{"date":"2025-01-17","current":-1.34638,"twenty":-17.952872,"median":-5.049325,"eighty":-1.971016,"marketCap":381603205},{"date":"2025-01-24","current":-1.435153,"twenty":-17.851225,"median":-5.015664,"eighty":-1.964286,"marketCap":406763856},{"date":"2025-01-31","current":-1.331585,"twenty":-17.750154,"median":-4.941866,"eighty":-1.957866,"marketCap":377409763},{"date":"2025-02-07","current":-1.117052,"twenty":-17.69419,"median":-4.886637,"eighty":-1.950502,"marketCap":316604857},{"date":"2025-02-14","current":-1.509129,"twenty":-17.571446,"median":-4.837622,"eighty":-1.930792,"marketCap":427731065},{"date":"2025-02-21","current":-1.6053,"twenty":-17.366922,"median":-4.790586,"eighty":-1.924363,"marketCap":454988437},{"date":"2025-02-28","current":-1.44255,"twenty":-17.20715,"median":-4.750065,"eighty":-1.91409,"marketCap":408860577},{"date":"2025-03-07","current":-1.612697,"twenty":-16.867307,"median":-4.704615,"eighty":-1.893374,"marketCap":457085158},{"date":"2025-03-14","current":-1.636296,"twenty":-16.626752,"median":-4.665479,"eighty":-1.878406,"marketCap":421493591},{"date":"2025-03-21","current":-1.366392,"twenty":-16.626752,"median":-4.608672,"eighty":-1.866779,"marketCap":351968875},{"date":"2025-03-28","current":-1.30735,"twenty":-16.626752,"median":-4.547892,"eighty":-1.852601,"marketCap":336760343},{"date":"2025-04-04","current":-1.214571,"twenty":-16.626752,"median":-4.48793,"eighty":-1.843149,"marketCap":312861222},{"date":"2025-04-11","current":-1.223005,"twenty":-16.62508,"median":-4.455728,"eighty":-1.835722,"marketCap":315033870},{"date":"2025-04-17","current":-1.223005,"twenty":-16.45925,"median":-4.412309,"eighty":-1.830828,"marketCap":315033870},{"date":"2025-04-25","current":-1.30735,"twenty":-16.185215,"median":-4.351703,"eighty":-1.821436,"marketCap":336760343},{"date":"2025-05-02","current":-1.443375,"twenty":-16.121631,"median":-4.308044,"eighty":-1.814293,"marketCap":371798916},{"date":"2025-05-09","current":-0.984891,"twenty":-15.93851,"median":-4.183507,"eighty":-1.800615,"marketCap":253698084},{"date":"2025-05-16","current":-0.962224,"twenty":-15.84995,"median":-4.054358,"eighty":-1.786437,"marketCap":242791197},{"date":"2025-05-23","current":-0.944886,"twenty":-15.697205,"median":-3.786835,"eighty":-1.769444,"marketCap":238416581},{"date":"2025-05-30","current":-1.022905,"twenty":-15.641519,"median":-3.713036,"eighty":-1.758081,"marketCap":258102354},{"date":"2025-06-06","current":-1.11826,"twenty":-15.57827,"median":-3.653074,"eighty":-1.742864,"marketCap":282162743},{"date":"2025-06-13","current":-1.213616,"twenty":-15.412588,"median":-3.588499,"eighty":-1.736216,"marketCap":306223132},{"date":"2025-06-20","current":-1.11826,"twenty":-15.331065,"median":-3.552731,"eighty":-1.719858,"marketCap":282162743},{"date":"2025-06-27","current":-1.040242,"twenty":-15.284607,"median":-3.502101,"eighty":-1.704741,"marketCap":262476970},{"date":"2025-07-03","current":-1.031573,"twenty":-15.151277,"median":-3.426482,"eighty":-1.682655,"marketCap":260289662},{"date":"2025-07-11","current":-1.092254,"twenty":-15.04398,"median":-3.307562,"eighty":-1.66818,"marketCap":275600819},{"date":"2025-07-18","current":-1.074917,"twenty":-14.94827,"median":-3.24487,"eighty":-1.6632,"marketCap":271226203},{"date":"2025-07-25","current":-1.308971,"twenty":-14.89082,"median":-3.18952,"eighty":-1.642864,"marketCap":330283521},{"date":"2025-08-01","current":-1.066248,"twenty":-14.754512,"median":-3.051147,"eighty":-1.62781,"marketCap":269038895},{"date":"2025-08-08","current":-0.910212,"twenty":-14.599653,"median":-2.958897,"eighty":-1.620095,"marketCap":229667349},{"date":"2025-08-15","current":-1.00213,"twenty":-14.523414,"median":-2.868955,"eighty":-1.610319,"marketCap":237412701},{"date":"2025-08-22","current":-1.048959,"twenty":-14.397145,"median":-2.802805,"eighty":-1.601213,"marketCap":248506752},{"date":"2025-08-29","current":-1.105153,"twenty":-14.212923,"median":-2.753889,"eighty":-1.597555,"marketCap":261819614},{"date":"2025-09-05","current":-1.039593,"twenty":-13.987033,"median":-2.729999,"eighty":-1.591702,"marketCap":246287942},{"date":"2025-09-12","current":-1.095787,"twenty":-13.860276,"median":-2.662614,"eighty":-1.583106,"marketCap":259600803},{"date":"2025-09-19","current":-1.13325,"twenty":-13.638068,"median":-2.618737,"eighty":-1.569834,"marketCap":268476045},{"date":"2025-09-26","current":-1.123885,"twenty":-13.381913,"median":-2.588753,"eighty":-1.556392,"marketCap":266257234},{"date":"2025-10-03","current":-1.208176,"twenty":-12.80805,"median":-2.553886,"eighty":-1.542679,"marketCap":286226527},{"date":"2025-10-10","current":-1.414221,"twenty":-12.108801,"median":-2.522766,"eighty":-1.523793,"marketCap":335040353},{"date":"2025-10-17","current":-1.189444,"twenty":-11.068438,"median":-2.503782,"eighty":-1.51608,"marketCap":281788906}],"updateTime":1760870620121},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALLO\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2575295527","title":"Allogene Therapeutics Faces Potential Risk as Cellectis Hit with Patent Infringement Lawsuit Over TALEN Gene-Editing Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2575295527","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2575295527?lang=en_us&edition=fundamental","pubTime":"2025-10-14 18:01","pubTimestamp":1760436077,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Faces Potential Risk as Cellectis Hit with Patent Infringement Lawsuit Over TALEN Gene-Editing Technology. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allogene Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 14, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251014:nNDL5g4k4J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1003077747.HKD","LU0889565080.SGD","LU0203347892.USD","LU1057294990.SGD","LU0114720955.EUR","LU2089284900.SGD","LU0969580561.USD","LU2114397693.USD","IE00BKPKM643.USD","LU0553294199.USD","LU0047473722.EUR","LU2133065610.SGD","LU0047473722.SGD","LU0972486137.USD","LU1481599808.USD","LU0310800965.SGD","LU0997586432.USD","LU0575583348.USD","LU0784383803.USD","LU1989772923.USD","LU0266013472.USD","LU0052756011.USD","AZN.UK","LU0128525689.USD","LU0784385170.HKD","LU1880407132.USD","LU2324357040.USD","LU1064927863.SGD","LU0957799991.USD","ALLO","LU0077335932.USD","LU2279689827.SGD","LU0211326839.USD","LU2468319806.SGD","LU1023059063.AUD","LU0964806797.USD","IE00BJJMRZ35.SGD","BK4139","LU1983299246.USD","LU0211326755.USD","IE0034235188.USD","03165","BK5011","LU2089283258.USD","LU1061106388.HKD","LU2091194634.USD","LU2108987350.USD","SGXZ57979304.SGD","LU1015430645.USD","LU0963555726.SGD"],"gpt_icon":0},{"id":"2574705124","title":"J.P. Morgan Sticks to Its Sell Rating for Allogene Therapeutics (ALLO)","url":"https://stock-news.laohu8.com/highlight/detail?id=2574705124","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574705124?lang=en_us&edition=fundamental","pubTime":"2025-10-10 17:45","pubTimestamp":1760089533,"startTime":"0","endTime":"0","summary":"In a report released today, Brian Cheng from J.P. Morgan maintained a Sell rating on Allogene Therapeutics. The company’s shares closed yesterday a...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-sell-rating-for-allogene-therapeutics-allo-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/j-p-morgan-sticks-to-its-sell-rating-for-allogene-therapeutics-allo-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALLO"],"gpt_icon":0},{"id":"2574147452","title":"U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, Doximity","url":"https://stock-news.laohu8.com/highlight/detail?id=2574147452","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574147452?lang=en_us&edition=fundamental","pubTime":"2025-10-10 15:16","pubTimestamp":1760080574,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Beacon Financial, Comerica, DoximityOct 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Beacon ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nL5N3VR08D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0466842654.USD","ZYME","DOCS","NRIX","DVN","PODD","IE00BJT1NW94.SGD","LU0868494617.USD","BEAM","BK4017","BTU","RGLD","GMED","TXN","BK4588","CNR","HL","COLB","OCFC","PLRX","MPWR","ALGN","NEM","JNJ","LSCC","MCHP","TSYW.SI","IE00B2B36J28.USD","BBT","ALLO","KIDS","CMA","HSII","CABA","WM","PEP","RSG","FANG","ZBH","ALGM","CDTX","ABBV","LU1629891620.HKD","XRAY","SSRM","INSP"],"gpt_icon":1},{"id":"2574146823","title":"Allogene Therapeutics Inc : JP Morgan Cuts to Underweight From Neutral","url":"https://stock-news.laohu8.com/highlight/detail?id=2574146823","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2574146823?lang=en_us&edition=fundamental","pubTime":"2025-10-10 12:45","pubTimestamp":1760071551,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251010:nFWN3VR0MX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2559989234","title":"Allogene Therapeutics Initiates Pivotal Phase 2 ALPHA3 Trial for Cema-Cel in Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989234","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989234?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:11","pubTimestamp":1755115879,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Inc., a clinical-stage biotechnology company specializing in allogeneic CAR T products, has announced updates on several key clinical trials. The pivotal Phase 2 ALPHA3 trial with Cemacabtagene Ansegedleucel  is progressing as a two-arm randomized study in first-line consolidation for large B-cell lymphoma, with more than 50 sites activated in the U.S. and Canada, and international expansion underway. A scheduled futility analysis is on track for the first half of 2026. Additionally, the company has initiated the Phase 1 RESOLUTION trial with ALLO-329 for autoimmune diseases, with proof-of-concept data expected in the first half of 2026. The Phase 1 TRAVERSE trial with ALLO-316 in renal cell carcinoma is also underway. Allogene will host a live conference call and webcast to discuss these developments and financial results, with a replay available on their website for 30 days following the event.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL8lbh7f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4139","ALLO"],"gpt_icon":0},{"id":"2559989251","title":"Allogene Therapeutics Reports Quarterly Financial Results; Key Milestones Achieved in Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989251","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989251?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:06","pubTimestamp":1755115584,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Inc. has reported its financial results for the second quarter of 2025, showing a net loss of $50.9 million, or $0.23 per share. This loss includes $8.7 million in non-cash stock-based compensation expense and a $2.4 million non-cash impairment of long-lived asset expense. The company's research and development expenses totaled $40.2 million, which includes $2.6 million of non-cash stock-based compensation expense. General and administrative expenses were $14.3 million, including $6.1 million of non-cash stock-based compensation expense. As of June 30, 2025, Allogene had $302.6 million in cash, cash equivalents, and investments. The quarter highlighted significant progress for Allogene, with advancements in the streamlined ALPHA3 trial, initiation of clinical enrollment in autoimmune indications with ALLO-329, and alignment with the FDA on a pivotal path for ALLO-316 in solid tumors.Disclaimer: This news brief was created by Public Technologies  using generative a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nNDL29kh53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","NDAQ","BK4588","LU2210150020.SGD","IE00BGHQF748.EUR","LU0314104364.USD","LU2095319765.USD","LU2210149790.SGD","IE00BKPKM429.USD","BK4139","ALLO","IE00B3QW5Z07.USD","BK4585","IE00B64PRP62.GBP","BK4112"],"gpt_icon":0},{"id":"2559989483","title":"BRIEF-Allogene Therapeutics Q2 EPS USD -0.23","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989483","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989483?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:05","pubTimestamp":1755115547,"startTime":"0","endTime":"0","summary":"BRIEF-Allogene Therapeutics Q2 EPS USD -0.23\n\n\nAug 13 (Reuters) - Allogene Therapeutics Q2 income from operations USD -56.819 million.\n\nQ2 basic EPS USD -0.23\nQ2 net income USD -50.943 million","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLX25E1A1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO"],"gpt_icon":0},{"id":"2559989119","title":"Allogene Therapeutics Q2 Net Income USD -50.943 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2559989119","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2559989119?lang=en_us&edition=fundamental","pubTime":"2025-08-14 04:05","pubTimestamp":1755115502,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250813:nPLX25E1A1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2557596306","title":"Relmada Therapeutics Reports Second Quarter 2025 Financial Results and Announces NDV-01 6-Month Follow-up Safety and Efficacy Data in NMIBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2557596306","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557596306?lang=en_us&edition=fundamental","pubTime":"2025-08-08 04:05","pubTimestamp":1754597100,"startTime":"0","endTime":"0","summary":"6-month follow-up for NDV-01 showed a 91% overall response rate at any time in non-muscle invasive bladder cancer, with good overall safety Enrollment in the Phase 2 study for NDV-01 continues, with u","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/08/07/3129672/0/en/Relmada-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Announces-NDV-01-6-Month-Follow-up-Safety-and-Efficacy-Data-in-NMIBC.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","IE00B1B80R65.USD","BK4179","BK4139","ALLO","BK4161","BK4007","TS","BK4505","BK4532","BK4539","PWS","CR"],"gpt_icon":0},{"id":"2557374287","title":"Allogene Therapeutics to Report Second Quarter 2025 Financial Results and Provide Business Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2557374287","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2557374287?lang=en_us&edition=fundamental","pubTime":"2025-08-06 20:30","pubTimestamp":1754483401,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250806:nTUA5RYV53:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ALLO","BK4505"],"gpt_icon":0},{"id":"2556389802","title":"JPMorgan Downgrades Allogene Therapeutics to Neutral From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2556389802","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556389802?lang=en_us&edition=fundamental","pubTime":"2025-08-04 19:47","pubTimestamp":1754308066,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics (ALLO) has an average rating of overweight and mean price target of $7.85, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research fr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LENZ","ALLO"],"gpt_icon":0},{"id":"2556805024","title":"U.S. RESEARCH ROUNDUP-Carvana, Federated Hermes, Ralph Lauren","url":"https://stock-news.laohu8.com/highlight/detail?id=2556805024","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556805024?lang=en_us&edition=fundamental","pubTime":"2025-08-04 15:39","pubTimestamp":1754293165,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-Carvana, Federated Hermes, Ralph Lauren Aug 4 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Carv","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nL4N3TW0G8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KNSL","RL","THC","ALLO","HWM","NOG","F","HCA","IE0004445239.USD","LU2543165471.USD","LU0310799852.SGD","FHI","LNC","LU1150488135.SGD","LU1642822529.SGD","BEN","MAS","CHD","BK4086","IE00B66KJ199.SGD","LU1543694498.USD","EBAY","RGA","UHS","AVNT","EPR","BK4533","LU0154236417.USD","IE00B19Z3B42.SGD","NSP","TROW","CVNA","LU2413665964.HKD","LU1712237335.SGD","GWW","LU1868837300.USD","LU0289960550.SGD","CBOE","GDDY","UNM","BE","WCC","CVS","IE00BSNM7G36.USD","SG9999014021.USD","LU2244417387.USD","LU1430594728.SGD","LU2764262908.HKD"],"gpt_icon":1},{"id":"2556587268","title":"Allogene Therapeutics Inc : JP Morgan Cuts to Neutral From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2556587268","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556587268?lang=en_us&edition=fundamental","pubTime":"2025-08-04 11:43","pubTimestamp":1754279031,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250804:nFWN3TT2Z2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2556284986","title":"Allogene Therapeutics Inc  expected to post a loss of 27 cents a share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2556284986","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556284986?lang=en_us&edition=fundamental","pubTime":"2025-08-02 05:47","pubTimestamp":1754084824,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Inc  expected to post a loss of27cents a share - Earnings Preview Allogene Therapeutics Inc ALLO.OQ ALLO.O is expected to  show a rise in quarterly revenue when it reports  resul","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nL8N3TT32F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO"],"gpt_icon":0},{"id":"2556081151","title":"BRIEF-Allogene Therapeutics Selects Standard FC Regimen For Alpha3 Study - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2556081151","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556081151?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:54","pubTimestamp":1754056490,"startTime":"0","endTime":"0","summary":"BRIEF-Allogene Therapeutics Selects Standard FC Regimen For Alpha3 Study - SEC FilingAug 1  - Allogene Therapeutics Inc ALLO.O:ALLOGENE THERAPEUTICS INC - SELECTS STANDARD FC REGIMEN FOR ALPHA3 STUDY - SEC FILINGALLOGENE THERAPEUTICS INC - FC PLUS ALLO-647 ARM CLOSED DUE TO ADVERSE EVENT - SEC FILINGALLOGENE THERAPEUTICS INC: NONE OF CO'S TRIALS OPEN TO ENROLLMENT OR PIPELINE PROGRAMS INCLUDE ALLO-647ALLOGENE THERAPEUTICS: WILL ADVANCE NEXT-GENERATION ALLOCAR T PRODUCT CANDIDATES USING PROPRIETARY DAGGER PLATFORM TECHNOLOGYALLOGENE THERAPEUTICS: GRADE 5 ADVERSE EVENT IN FC PLUS ALLO-647 ARM ATTRIBUTED TO USE OF ALLO-647Source text: [ID:n0001193125-25-171091]Further company coverage: ALLO.O ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1DF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2556819543","title":"Allogene Therapeutics Inc: None of Co's Trials Open to Enrollment or Pipeline Programs Include Allo-647","url":"https://stock-news.laohu8.com/highlight/detail?id=2556819543","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556819543?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:27","pubTimestamp":1754054821,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1DF:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2556599819","title":"Allogene Therapeutics Inc - Fc Plus Allo-647 Arm Closed Due to Adverse Event - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2556599819","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556599819?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:27","pubTimestamp":1754054821,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1DF:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2556195488","title":"Allogene Therapeutics: Will Advance Next-Generation Allocar T Product Candidates Using Proprietary Dagger Platform Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2556195488","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556195488?lang=en_us&edition=fundamental","pubTime":"2025-08-01 21:27","pubTimestamp":1754054821,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nFWN3TT1DF:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALLO","BK4139","BK4505"],"gpt_icon":0},{"id":"2556815290","title":"Allogene Therapeutics Announces Launch of ALPHA3 Study Using Standard Fludarabine and Cyclophosphamide for Large B-Cell Lymphoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2556815290","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2556815290?lang=en_us&edition=fundamental","pubTime":"2025-08-01 20:30","pubTimestamp":1754051428,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Announces Launch of ALPHA3 Study Using Standard Fludarabine and Cyclophosphamide for Large B-Cell Lymphoma. Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allogene Therapeutics Inc. published the original content used to generate this news brief via GlobeNewswire  on August 01, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250801:nNDL2mc4l8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4585","LU2210150020.SGD","IE00BGHQF748.EUR","NDAQ","IE00BKPKM429.USD","BK4139","ALLO","LU2210149790.SGD","LU2095319765.USD","BK4505","BK4588","LU0314104364.USD","BK4112","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2545447269","title":"Allogene Therapeutics Inc. Conducted Annual Stockholders Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2545447269","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2545447269?lang=en_us&edition=fundamental","pubTime":"2025-06-24 04:28","pubTimestamp":1750710532,"startTime":"0","endTime":"0","summary":"Allogene Therapeutics Inc. held its Annual Meeting of Stockholders on June 18, 2025. During the meeting, stockholders elected Elizabeth Barrett, Arie Belldegrun, M.D., and David Chang, M.D., Ph.D., as Class I Directors. The compensation of the company's named executive officers was approved on an advisory basis. Additionally, the selection of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, was ratified.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Allogene Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250623:nNDL9vxSYb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALLO","BK4139","BK4505"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}